Recombinant Human MICA Fc Chimera Protein, CF Summary
Product Specifications
Human MICA (Ala23 - Gln308) Accession # NP_001170990 |
IEGRMD | Human IgG1 (Pro100 - Lys330) |
N-terminus | C-terminus | |
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
1300-MA
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: MICA
MICA (MHC class I chain-related gene A) is a transmembrane glycoprotein that functions as a ligand for human NKG2D. A closely related protein, MICB, shares 85% amino acid identity with MICA. These proteins are distantly related to the MHC class I proteins. They possess three extracellular Ig‑like domains, but they have no capacity to bind peptide or interact with beta 2-microglobulin. The genes encoding these proteins are found within the Major Histocompatibility Complex on human chromosome 6. The MICA locus is highly polymorphic with more than 50 recognized human alleles. MICA is absent from most cells but is frequently expressed in epithelial tumors and can be induced by bacterial and viral infections. MICA is a ligand for human NKG2D, an activating receptor expressed on NK cells, NKT cells, gamma δ T cells, and CD8+ alpha beta T cells. Recognition of MICA by NKG2D results in the activation of cytolytic activity and/or cytokine production by these effector cells. MICA recognition is involved in tumor surveillance, viral infections, and autoimmune diseases.
- Groh, V. et al. (2001) Nature Immunol. 2:255.
- Stephens, H. (2001) Trends Immunol. 22:378.
- Bauer, S. et al. (1999) Science 285:727.
- Groh, V. et al. (2002) Nature 419:734.
- Steinle, A. et al. (2001) Immunogenetics 53:279.
- Pende, D. et al. (2002) Cancer Res. 62:6178.
- NKG2D and its Ligands (2002) http://www.RnDSystems.com
Citations for Recombinant Human MICA Fc Chimera Protein, CF
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
11
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome
Authors: Seller, A;Tegeler, CM;Mauermann, J;Schreiber, T;Hagelstein, I;Liebel, K;Koch, A;Heitmann, JS;Greiner, SM;Hayn, C;Dannehl, D;Engler, T;Hartkopf, AD;Hahn, M;Brucker, SY;Salih, HR;Märklin, M;
International journal of molecular sciences
Species: Human
Sample Types: Serum
Applications: ELISA Standard -
Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion
Authors: JA Myers, D Schirm, L Bendzick, R Hopps, C Selleck, P Hinderlie, M Felices, JS Miller
JCI Insight, 2022-08-08;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome
Authors: A Gil-Krzews, MB Saeed, A Oszmiana, ER Fischer, K Lagrue, WA Gahl, WJ Introne, JE Coligan, DM Davis, K Krzewski
J. Allergy Clin. Immunol., 2017-12-11;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition
Authors: AB Raneros, AM Puras, RM Rodriguez, E Colado, T Bernal, E Anguita, AV Mogorron, AC Gil, JR Vidal-Cast, L Márquez-Ki, PD Bulnes, AM Marin, MCG Garay, B Suarez-Alv, C Lopez-Larr
Oncotarget, 2017-05-09;8(19):31959-31976.
Species: Human
Sample Types: Cell Culture Supernates
Applications: ELISA (Standard) -
Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds.
Authors: Lagrue K, Carisey A, Morgan D, Chopra R, Davis D
Blood, 2015-05-22;126(1):50-60.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Super-resolution imaging of remodeled synaptic actin reveals different synergies between NK cell receptors and integrins.
Authors: Brown A, Dobbie I, Alakoskela J, Davis I, Davis D
Blood, 2012-09-10;120(18):3729-40.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS.
Authors: Guerra S, Gonzalez JM, Climent N, Reyburn H, Lopez-Fernandez LA, Najera JL, Gomez CE, Garcia F, Gatell JM, Gallart T, Esteban M
J. Virol., 2010-06-09;84(16):8141-52.
Applications: ELISA (Standard) -
The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia.
Authors: Nuckel H, Switala M, Sellmann L, Horn PA, Durig J, Duhrsen U, Kuppers R, Grosse-Wilde H, Rebmann V
Leukemia, 2010-04-29;24(6):1152-9.
Applications: ELISA (Standard) -
Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity.
Authors: Kwong KY, Baskar S, Zhang H, Mackall CL, Rader C
J. Mol. Biol., 2008-09-16;384(5):1143-56.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities.
Authors: Diermayr S, Himmelreich H, Durovic B, Mathys-Schneeberger A, Siegler U, Langenkamp U, Hofsteenge J, Gratwohl A, Tichelli A, Paluszewska M, Wiktor-Jedrzejczak W, Kalberer CP, Wodnar-Filipowicz A
Blood, 2007-11-09;111(3):1428-36.
Applications: ELISA (Standard) -
Human cytomegalovirus-encoded UL16 discriminates MIC molecules by their alpha2 domains.
Authors: Spreu J, Stehle T, Steinle A
J. Immunol., 2006-09-01;177(5):3143-9.
Species: Human
Sample Types: Recombinant Protein
Applications: Binding Assay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human MICA Fc Chimera Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human MICA Fc Chimera Protein, CF and earn rewards!
Have you used Recombinant Human MICA Fc Chimera Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image